Literature DB >> 34345878

Air-liquid interface cultures of the healthy and diseased human respiratory tract: promises, challenges and future directions.

Domizia Baldassi1, Bettina Gabold1, Olivia Merkel1.   

Abstract

Air-liquid interface (ALI) culture models currently represent a valid instrument to recreate the typical aspects of the respiratory tract in vitro in both healthy and diseased state. They can help reducing the number of animal experiments, therefore, supporting the 3R principle. This review discusses ALI cultures and co-cultures derived from immortalized as well as primary cells, which are used to study the most common disorders of the respiratory tract, in terms of both pathophysiology and drug screening. The article displays ALI models used to simulate inflammatory lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, cystic fibrosis, lung cancer, and viral infections. It also includes a focus on ALI cultures described in literature studying respiratory viruses such as SARS-CoV-2 causing the global Covid-19 pandemic at the time of writing this review. Additionally, commercially available models of ALI cultures are presented. Ultimately, the aim of this review is to provide a detailed overview of ALI models currently available and to critically discuss them in the context of the most prevalent diseases of the respiratory tract.

Entities:  

Keywords:  3D co-culture models; SARS Cov-2; air-liquid interface; lung; pulmonary administration; respiratory tract

Year:  2021        PMID: 34345878      PMCID: PMC7611446          DOI: 10.1002/anbr.202000111

Source DB:  PubMed          Journal:  Adv Nanobiomed Res        ISSN: 2699-9307


  156 in total

1.  Coadministration of a tumor-penetrating peptide improves the therapeutic efficacy of paclitaxel in a novel air-grown lung cancer 3D spheroid model.

Authors:  Sweta K Gupta; Elisa A Torrico Guzmán; Samantha A Meenach
Journal:  Int J Cancer       Date:  2017-08-18       Impact factor: 7.396

2.  Animal models of asthma: Pro: Allergic avoidance of animal (model[s]) is not an option.

Authors:  Steven D Shapiro
Journal:  Am J Respir Crit Care Med       Date:  2006-12-01       Impact factor: 21.405

3.  Diesel exhaust particle-exposed human bronchial epithelial cells induce dendritic cell maturation.

Authors:  Bertram Bleck; Doris B Tse; Ilona Jaspers; Maria A Curotto de Lafaille; Joan Reibman
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

4.  Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition.

Authors:  Sophie T Gohy; Cloé Hupin; Chantal Fregimilicka; Bruno R Detry; Caroline Bouzin; Héloïse Gaide Chevronay; Marylène Lecocq; Birgit Weynand; Maha Z Ladjemi; Christophe E Pierreux; Philippe Birembaut; Myriam Polette; Charles Pilette
Journal:  Eur Respir J       Date:  2015-03-05       Impact factor: 16.671

5.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 6.  Air-Liquid Interface: Relevant In Vitro Models for Investigating Air Pollutant-Induced Pulmonary Toxicity.

Authors:  Swapna Upadhyay; Lena Palmberg
Journal:  Toxicol Sci       Date:  2018-07-01       Impact factor: 4.849

Review 7.  Animal and model systems for studying cystic fibrosis.

Authors:  Bradley H Rosen; Marc Chanson; Lara R Gawenis; Jinghua Liu; Aderonke Sofoluwe; Alice Zoso; John F Engelhardt
Journal:  J Cyst Fibros       Date:  2017-09-19       Impact factor: 5.482

8.  Characterization of pediatric cystic fibrosis airway epithelial cell cultures at the air-liquid interface obtained by non-invasive nasal cytology brush sampling.

Authors:  Aline Schögler; Fabian Blank; Melanie Brügger; Seraina Beyeler; Stefan A Tschanz; Nicolas Regamey; Carmen Casaulta; Thomas Geiser; Marco P Alves
Journal:  Respir Res       Date:  2017-12-28

9.  Multilayered Cultures of NSCLC cells grown at the Air-Liquid Interface allow the efficacy testing of inhaled anti-cancer drugs.

Authors:  Dania Movia; Despina Bazou; Yuri Volkov; Adriele Prina-Mello
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

10.  Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.

Authors:  Roujian Lu; Xiang Zhao; Juan Li; Peihua Niu; Bo Yang; Honglong Wu; Wenling Wang; Hao Song; Baoying Huang; Na Zhu; Yuhai Bi; Xuejun Ma; Faxian Zhan; Liang Wang; Tao Hu; Hong Zhou; Zhenhong Hu; Weimin Zhou; Li Zhao; Jing Chen; Yao Meng; Ji Wang; Yang Lin; Jianying Yuan; Zhihao Xie; Jinmin Ma; William J Liu; Dayan Wang; Wenbo Xu; Edward C Holmes; George F Gao; Guizhen Wu; Weijun Chen; Weifeng Shi; Wenjie Tan
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

View more
  7 in total

1.  Transferrin-modified chitosan nanoparticles for targeted nose-to-brain delivery of proteins.

Authors:  Bettina Gabold; Friederike Adams; Sophie Brameyer; Kirsten Jung; Christian L Ried; Thomas Merdan; Olivia M Merkel
Journal:  Drug Deliv Transl Res       Date:  2022-10-07       Impact factor: 5.671

2.  Immunofluorescence-Mediated Detection of Respiratory Virus Infections in Human Airway Epithelial Cultures.

Authors:  Talita B Gagliardi; Ethan Iverson; Emma J DeGrace; Brad R Rosenberg; Margaret A Scull
Journal:  Curr Protoc       Date:  2022-06

Review 3.  Muscarinic receptor antagonists and airway inflammation: A systematic review on pharmacological models.

Authors:  Luigino Calzetta; Elena Pistocchini; Beatrice Ludovica Ritondo; Francesco Cavalli; Francesca Camardelli; Paola Rogliani
Journal:  Heliyon       Date:  2022-06-22

4.  Can pulmonary RNA delivery improve our pandemic preparedness?

Authors:  Olivia M Merkel
Journal:  J Control Release       Date:  2022-03-28       Impact factor: 11.467

5.  Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes.

Authors:  Domizia Baldassi; Shubhankar Ambike; Martin Feuerherd; Cho-Chin Cheng; David J Peeler; Daniel P Feldmann; Diana Leidy Porras-Gonzalez; Xin Wei; Lea-Adriana Keller; Nikolaus Kneidinger; Mircea Gabriel Stoleriu; Andreas Popp; Gerald Burgstaller; Suzie H Pun; Thomas Michler; Olivia M Merkel
Journal:  J Control Release       Date:  2022-03-29       Impact factor: 11.467

6.  Air-Liquid-Interface Differentiated Human Nose Epithelium: A Robust Primary Tissue Culture Model of SARS-CoV-2 Infection.

Authors:  Bang M Tran; Samantha L Grimley; Julie L McAuley; Abderrahman Hachani; Linda Earnest; Sharon L Wong; Leon Caly; Julian Druce; Damian F J Purcell; David C Jackson; Mike Catton; Cameron J Nowell; Laura Leonie; Georgia Deliyannis; Shafagh A Waters; Joseph Torresi; Elizabeth Vincan
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

7.  Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?

Authors:  Gemma Conte; Gabriella Costabile; Domizia Baldassi; Valeria Rondelli; Rosaria Bassi; Diego Colombo; Giulia Linardos; Ersilia V Fiscarelli; Raffaella Sorrentino; Agnese Miro; Fabiana Quaglia; Paola Brocca; Ivana d'Angelo; Olivia M Merkel; Francesca Ungaro
Journal:  ACS Appl Mater Interfaces       Date:  2022-02-02       Impact factor: 9.229

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.